Close
Nordic 9Nordic 9

Titian Capital (investor - Others)

United Arab Emirates
See something wrong or missing? Let us know
Offices:Dubai

Titian Capital is a Dubai UAE-based private family office managed by Kayaan Unwalla, with interests across life sciences, AI, digital advertising, and infrastructure.

Average round investment:12M USD
Average number per year:1.0
Distribution: 2025 (1)
Portfolio companies: Sweden Cellcolabs
Mostly invests in: Sweden Sweden (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Titian Capital

Name Criteria
Sweden Bengt Julander
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Linc Invest
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Riyadh Valley Company
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Amino Capital
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Sweden JOvB Investment AB
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States E14 Fund
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Sweden Ash Pournouri
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Sweden Beijer Ventures AB
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
Germany L&R Ventures
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
United States The Venture Collective
73%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Top